Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Net Margin (2020 - 2025)

Historic Net Margin for Rani Therapeutics Holdings (RANI) over the last 5 years, with Q1 2025 value amounting to 7405.81%.

  • Rani Therapeutics Holdings' Net Margin changed N/A to 7405.81% in Q1 2025 from the same period last year, while for Sep 2025 it was 3966.5%, marking a year-over-year decrease of 82039200.0%. This contributed to the annual value of 5504.28% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Rani Therapeutics Holdings reported Net Margin of 7405.81% as of Q1 2025.
  • Over the past 5 years, Rani Therapeutics Holdings' Net Margin peaked at 1474.25% during Q2 2023, and registered a low of 7405.81% during Q1 2025.
  • Moreover, its 4-year median value for Net Margin was 402.39% (2021), whereas its average is 576.14%.
  • Per our database at Business Quant, Rani Therapeutics Holdings' Net Margin skyrocketed by 42436300bps in 2021 and then plummeted by -26138700bps in 2024.
  • Rani Therapeutics Holdings' Net Margin (Quarter) stood at 279.7% in 2021, then surged by 488bps to 1084.49% in 2023, then plummeted by -241bps to 1529.38% in 2024, then plummeted by -384bps to 7405.81% in 2025.
  • Its Net Margin stands at 7405.81% for Q1 2025, versus 1529.38% for Q4 2024 and 1084.49% for Q4 2023.